CNC vs MOH vs CLOV Stock Comparison

Centene, Molina Healthcare and Clover Health Investments Prices as of Nov 13, 2026 Peers: Industry group
CNC Centene Corp
$71.26 +1.6% 1M +97.5% 1Y
Market cap
$35.04B
P/E
–
Revenue (TTM)
$194.78B
Div. yield
–
Managed Care Healthcare
4 wins
MOH Molina Healthcare, Inc.
$209.62 +0.3% 1M +51.4% 1Y
Market cap
$10.90B
P/E
–
Revenue (TTM)
$44.13B
Div. yield
–
Managed Care Healthcare
2 wins

Head to Head

10 decided of 12

Centene leads on 4 of the 12 questions below (Centene 4, Clover Health Investments 4, Molina Healthcare 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionCNCMOHCLOVLeader
Larger companyMarket capitalisation $35.04B $10.90B $2.65B CNC
Cheaper on earningsLower P/E, profitable companies only -5.3x -223.6x 211.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 13.1x 41.0x 82.7x CNC
Faster revenue growthRevenue growth, trailing twelve months +19.4% -0.9% +54.5% CLOV
More profitableNet margin, trailing twelve months -3.4% -0.1% 0.5% CLOV
Better return on capitalReturn on invested capital -19.9% 2.2% — MOH
Less leveragedLower net debt / EBITDA 0.0x -14.4x — MOH
Higher dividend yieldTrailing dividend yield — — — –
Better 1-year returnPrice return, last 12 months +97.5% +51.4% +100.8% CLOV
Better 5-year returnAnnualised price return, 5 years -1.2%/yr -7.7%/yr -7.1%/yr CNC
Less volatileAnnualised volatility, 1 year 46.4% 52.5% 59.0% CNC
Higher overall scoreMean of the five percentile scores vs peers 51/100 36/100 57/100 CLOV

Percentile Scorecard

CNCMOHCLOV

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisCNCMOHCLOV
Valuation 92 #3 of 27 42 #16 of 27 39 #17 of 27
Growth 28 #19 of 26 4 #25 of 26 96 #2 of 26
Profitability 36 #17 of 26 32 #18 of 26 44 #15 of 26
Financial Health 36 #17 of 26 64 #10 of 26 84 #5 of 26
Shareholder Returns 65 #7 of 18 – 24 #14 of 18
Overall 51 36 57
  • CNC ranked among 27 companies in Healthcare Payers and Distributors
  • MOH ranked among 27 companies in Healthcare Payers and Distributors
  • CLOV ranked among 27 companies in Healthcare Payers and Distributors

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodCNCMOHCLOVSPY
1 month +1.6%+0.3%+3.5% -2.0%
3 months +5.6%-1.3%+7.8% -2.8%
6 months +22.3%+13.3%+42.9% +2.0%
Year to date +73.2%+20.8%+111.1% +10.6%
1 year +97.5%+51.4%+100.8% +12.2%
3 years -2.7%-42.2%+391.1% +68.1%
3 years, per year -0.9%-16.7%+70.0% +18.9%
5 years -6.1%-33.1%-30.7% +61.4%
5 years, per year -1.2%-7.7%-7.1% +10.1%
10 years +181.2%+341.0%— +248.5%
10 years, per year +10.9%+16.0%— +13.3%

Risk

MeasureCNCMOHCLOVSPY
Volatility, 1Y 46.4%52.5%59.0% 13.6%
Downside volatility, 1Y 45.1%57.9%48.9% 13.9%
Beta vs S&P 500, 1Y 0.46-0.011.11 1.00
Return / volatility, 1Y 2.100.981.71 0.90
Max drawdown, 5Y -74.1%-70.8%-91.8% -25.4%
From 52-week high -6.2%-13.7%-8.3% -3.2%
52-week high $75.99$242.88$5.41 $779.14
52-week low $31.80$122.65$1.70 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleCNCMOHCLOV
P/E now vs peer median -5.3xmedian 25.2x -223.6xmedian 25.2x 211.8xmedian 25.2x
P/S now vs peer median 0.2xmedian 0.4x 0.2xmedian 0.4x 1.0xmedian 0.4x
EV/EBITDA now vs peer median 0.2xmedian 14.5x 18.3xmedian 14.5x 170.0xmedian 14.5x
P/FCF now vs peer median 8.1xmedian 16.5x 45.8xmedian 16.5x 20.0xmedian 16.5x
P/B now vs peer median 1.7xmedian 2.7x 2.6xmedian 2.7x 6.8xmedian 2.7x
PEG now vs peer median 0.05median 1.72 8.22median 1.72 7.85median 1.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsCNCMOHCLOV
Revenue $194.78B $44.13B $2.74B
Gross profit $37.08B $5.56B $516.60M
Operating income -$7.62B $172.00M $12.45M
Net income -$6.68B -$48.00M $12.45M
Free cash flow $4.32B $238.00M $132.28M
EPS (diluted) $-13.53 $-0.93 $0.02
Cash & equivalents $17.89B $4.48B $268.07M
Total debt $17.40B $3.77B –
Shares (diluted) 493.12M 51.50M 557.48M
Enterprise value -$39.00B -$24.10B $1.87B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricCNCMOHCLOV
P/E -5.3x -223.6x 211.8x
P/FCF 8.1x 45.8x 20.0x
P/Operating cash flow 6.9x 32.9x 19.6x
P/S 0.2x 0.2x 1.0x
P/B 1.7x 2.6x 6.8x
P/Tangible book 2.3x 2.6x 6.8x
EV/EBITDA 0.2x 18.3x 170.0x
EV/EBIT -4.2x 35.4x 186.3x
EV/Revenue 0.2x 0.1x 0.8x
EV/FCF 7.4x 25.6x 17.5x
EV/Operating cash flow 6.3x 18.4x 17.1x
PEG (3Y EPS CAGR) 0.05 8.22 7.85

Growth

14 metrics
MetricCNCMOHCLOV
Revenue growth (1Y) 19.4% -0.9% 54.5%
Revenue CAGR (3Y) 10.5% 9.9% 92.5%
Gross profit growth (1Y) -0.8% -10.2% 37.5%
Gross profit CAGR (3Y) 3.9% 3.3% 22.8%
Operating income growth (1Y) -340.1% -87.0% 121.6%
Operating income CAGR (3Y) -98.2% -49.8% 27.6%
Net income growth (1Y) -302.0% -105.4% 121.3%
Net income CAGR (3Y) -96.3% -27.1% 27.1%
EPS growth (1Y) -314.5% -105.5% 119.6%
EPS CAGR (3Y) -104.5% -27.2% 27.0%
Operating cash flow growth (1Y) 3,204% 171.8% 395.0%
Operating cash flow CAGR (3Y) -6.7% -46.3% 39.0%
Free cash flow growth (1Y) 981.8% 141.5% 377.7%
Free cash flow CAGR (3Y) -6.3% -51.1% 38.5%

Profitability

14 metrics
MetricCNCMOHCLOV
Gross margin 19.0% 12.6% 18.9%
EBITDA margin 84.8% 0.8% 0.5%
Operating margin -3.9% 0.4% 0.5%
Pretax margin -3.5% -0.1% 0.5%
Net margin -3.4% -0.1% 0.5%
FCF margin 2.2% 0.5% 4.8%
Operating cash flow margin 2.6% 0.8% 4.9%
Return on equity -32.5% -1.2% 2.9%
Return on assets -8.4% -0.3% 1.5%
Return on invested capital -19.9% 2.2% –
Return on capital employed -17.9% 2.0% 3.2%
Asset turnover 2.5x 2.8x 3.7x
Cash conversion (OCF / net income) -0.8x -6.9x 10.9x
Stock comp / revenue 0.1% 0.2% 2.0%

Financial Health

11 metrics
MetricCNCMOHCLOV
Debt / assets 22.7% 24.1% –
Debt / equity 0.9x 0.9x –
Net debt / EBITDA 0.0x -14.4x –
Debt / FCF 4.0x 15.8x –
Liabilities / assets 73.9% 73.5% 48.1%
Equity / assets 26.1% 26.5% 51.9%
Interest coverage -11.2x 0.8x –
Current ratio 1.1x 1.7x 1.5x
Quick ratio 1.0x 1.6x 0.9x
Cash ratio 0.6x 1.2x 0.9x
Altman Z-score 2.80 4.15 4.23

Shareholder Returns

7 metrics
MetricCNCMOHCLOV
Dividend yield – – –
Net buyback yield 1.2% – 0.0%
Shareholder yield 1.2% – 0.0%
Payout ratio (earnings) – – –
Payout ratio (FCF) – – –
Dividend growth (1Y) – – –
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusCNCMOHCLOV
Forward P/E 13.1xFY2026 41.0xFY2026 82.7xFY2026
EPS, next fiscal year $5.44FY2026 $5.11FY2026 $0.06FY2026
EPS growth, next FY +161.5%FY2026 -53.7%FY2026 +50.0%FY2026
EPS growth, the year after +8.1% +93.0% +83.3%
Revenue, next fiscal year $206.34BFY2026 $41.59BFY2026 $2.83BFY2026
Revenue growth, next FY +5.9%FY2026 -8.5%FY2026 +47.2%FY2026
Revenue growth, the year after -1.2% +20.4% +34.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersCNCMOHCLOV
Held by institutions 97.9% 100.0% 27.6%
Institutions holding 1,001 600 227
Change in shares held, QoQ +2.1% +1.2% +14.4%
Institutions buying 569 364 124
Institutions selling 334 170 55
Buyers to sellers 1.70 2.14 2.25

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

CNCMOHCLOV
CNC 1.00 0.57 0.29
MOH 0.57 1.00 0.17
CLOV 0.29 0.17 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, CNC, MOH and CLOV?

Centene (CNC) is the largest by market capitalisation: Centene (CNC) $35.04B, Molina Healthcare (MOH) $10.90B, Clover Health Investments (CLOV) $2.65B.

Which company is growing faster?

Clover Health Investments (CLOV) grew revenue fastest over the trailing twelve months: Centene (CNC) +19.4%, Molina Healthcare (MOH) -0.9%, Clover Health Investments (CLOV) +54.5%.

Which company is more profitable?

Clover Health Investments (CLOV) has the highest net margin (Centene (CNC) -3.4%, Molina Healthcare (MOH) -0.1%, Clover Health Investments (CLOV) 0.5%). On return on invested capital, Molina Healthcare (MOH) leads (Centene (CNC) -19.9%, Molina Healthcare (MOH) 2.2%).

Which stock has performed better?

Over the past year Clover Health Investments (CLOV) returned the most: Centene (CNC) +97.5%, Molina Healthcare (MOH) +51.4%, Clover Health Investments (CLOV) +100.8%. Over five years, Centene (CNC) compounded fastest (Centene (CNC) -1.2%/yr, Molina Healthcare (MOH) -7.7%/yr, Clover Health Investments (CLOV) -7.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Centene (CNC) has been the steadiest (Centene (CNC) 46.4%, Molina Healthcare (MOH) 52.5%, Clover Health Investments (CLOV) 59.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, CNC, MOH and CLOV?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Centene (CNC) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.